Little Green Pharma's (LGP) recent partnership with HIF puts a spotlight on the often overlooked medicinal cannabis treatments
The significant rebate for LGP's cannabis oil treatments makes the product more affordable and allows it to compete for a slice of the pharmaceutical market
The global pharma market is already estimated to be worth US$1.25 trillion (around A$1.72 trillion) while in Australia, it's valued at around $25 billion
The company also believes the HIF deal could make it easier for Australian consumers to receive its products in a market where medicinal cannabis treatments can be difficult to access
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)